Cargando…
Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment
Purpose: Cancer is a global public health problem that affects millions of people every year and the immunotherapy has been a promising alternative for its treatment. The aim of this study was to gather data concerning the efficacy and safety of immunotherapy in the treatment of non-small cell lung...
Autores principales: | Miquelotti, Luísa Biscaglia, Sari, Marcel Henrique Marcondes, Ferreira, Luana Mota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871265/ https://www.ncbi.nlm.nih.gov/pubmed/36721805 http://dx.doi.org/10.34172/apb.2023.007 |
Ejemplares similares
-
A Fatal Case of Pembrolizumab-Induced Myocarditis in Non–Small Cell Lung Cancer
por: Cohen, Max, et al.
Publicado: (2020) -
The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
por: Ke, Wanhai, et al.
Publicado: (2020) -
Status and Future Scope of Soft Nanoparticles-Based Hydrogel in Wound Healing
por: Sari, Marcel Henrique Marcondes, et al.
Publicado: (2023) -
Curative effect assessment of immunotherapy for non‐small cell lung cancer: The “blind area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)
por: Song, Peng, et al.
Publicado: (2019) -
Comparison and discussion of the treatment guidelines for small cell lung cancer
por: Zhao, Honglin, et al.
Publicado: (2018)